Verona Pharma

Respiratory and Pulmonary

Verona Pharma

Verona Pharma (LSE: VRP), a UK-based biotechnology company, is dedicated to discovering new drugs to treat chronic respiratory diseases.

Verona Pharma (LSE: VRP), a UK-based biotechnology company, is dedicated to discovering new drugs to treat chronic respiratory diseases. The company’s lead drug compound is RPL554 for severe chronic obstructive pulmonary disease (COPD) in hospitals and home care settings. It is an inhibitor of both phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4) enzymes, two enzymes known to be of importance in respiratory diseases. The inhaled drug has the potential to act as both a bronchodilator and an anti-inflammatory which would significantly differentiate it from existing drugs.


Latest Articles

Back to top